comparison of hormone receptor status in primary and recurrent breast cancer

نویسندگان

hamid saeedi saedi dept. of radiation oncology, cancer research center, gilan university of medical sciences, rasht, iran

mohammad-reza ghavam nasiri dept. of radiation oncology, cancer research center , mashhad university of medical sciences, mashhad, iran

soodabeh shahidsales dept. of radiation oncology, cancer research center , mashhad university of medical sciences, mashhad, iran

ali taghizadeh dept. of radiation oncology, cancer research center , mashhad university of medical sciences, mashhad, iran

چکیده

background: systematic treatments such as hormone and chemotherapy are selected according to tumor characteristic after major therapeutic approaches such as surgery. this study attempted to analyze and compare the status of estrogen receptor (er) and progesterone receptor (pr) in primary and recurrent sites of breast cancer in patients. methods: we reviewed all medical records of breast cancer women who were treated between january 1995 and december 2008. one hundred eighty two out of 2241 patients (8.12%) had a metastatic breast cancer. amongst them 48 patients had tumor and biopsy-driven samples, however 13 samples were destroyed and only 35 samples were investigated in this study, therefore 35 malignant biopsy specimens of breast cancer patients were examined by immunohistochemistry essay for er and pr. binominal proportional test and chi square test were conducted to determine the significant correlation between positive cases of hormone receptors among primary and metastases sites. results: hormone receptor in the primary tumor (hr1) of 9 patients (25.7%) was positive (er1 and/or pr1) and in the recurrent areas (hr2) of 8 patients (22.9%) was positive (either er2 or pr2 positive). kappa coefficients of diagnostic agreement in primary and recurrent cases were 0.077 and 0.125 for estrogen and progesterone, respectively which indicated that the amount of coefficient of agreement is not considerable between primary and recurrent sites. conclusion: the current study indicated that receptor status in recurrent tumors did not pose predictable value based on the analysis of hormone receptors in primary stage, so it is not an appropriate basis to set up therapeutic protocol in the metastatic patients. therefore, tissue sampling and hormone receptor re-analyzing of metastatic sites should be considered in these cases.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Comparison of Hormone Receptor Status in Primary and Recurrent Breast Cancer

BACKGROUND Systematic treatments such as hormone and chemotherapy are selected according to tumor characteristic after major therapeutic approaches such as surgery. This study attempted to analyze and compare the status of Estrogen Receptor (ER) and Progesterone Receptor (PR) in primary and recurrent sites of breast cancer in patients. METHODS We reviewed all medical records of breast cancer ...

متن کامل

Second primary breast cancer occurrence according to hormone receptor status.

BACKGROUND Contralateral second primary breast cancers occur in 4% of female breast cancer survivors. Little is known about differences in risk for second primary breast cancers related to the estrogen and progesterone receptor (hormone receptor [HR]) status of the first tumor. METHODS We calculated standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for contralateral prim...

متن کامل

Steroidal Hormone Receptor Expression in Male Breast Cancer

Introduction: The etiology of male breast cancer is unclear, but hormonal levels may play a role in development of this disease. It seems that the risk of male breast cancer related to increased lifelong exposure to estrogen or reduced androgen. The aim of this study was to investigate the expression of the steroid hormone receptors including estrogen receptor (ER) and progesterone receptor (PR...

متن کامل

the study of aaag repeat polymorphism in promoter of errg gene and its association with the risk of breast cancer in isfahan region

چکیده: سرطان پستان دومین عامل مرگ مرتبط با سرطان در خانم ها است. از آنجا که سرطان پستان یک تومور وابسته به هورمون است، می تواند توسط وضعیت هورمون های استروئیدی شامل استروژن و پروژسترون تنظیم شود. استروژن نقش مهمی در توسعه و پیشرفت سرطان پستان ایفا می کند و تاثیر خود را روی بیان ژن های هدف از طریق گیرنده های استروژن اعمال می کند. اما گروه دیگری از گیرنده های هسته ای به نام گیرنده های مرتبط به ا...

15 صفحه اول

Hormone Receptor Status And Obesity Affect Risk Of Breast Cancer

First, some words about body shapes. Most men tend to be "apples" in that they carry most of their weight above the waist. Most women, on the other hand, are "pears", carrying more of their weight in the hips and thighs, as shown in the figure above. However, some women are more like apples, and their weight is distributed more like that of men. And if apples and pears become obese, these diffe...

متن کامل

Hormone receptor status and survival of medullary breast cancer patients

OBJECTIVES To analyze the relationship between clinical features, hormonal receptor status, and survival in patients who were diagnosed with medullary breast cancer (MBC). Methods: Demographic characteristics, histopathological features, and survival statuses of 201 patients diagnosed with MBC between 1995 and 2015 were retrospectively recorded. Survival analyses were conducted with uni- and mu...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of cancer prevention

جلد ۵، شماره ۲، صفحات ۶۹-۷۳

کلمات کلیدی
[ ' b r e a s t n e o p l a s m ' , ' p r o g e s t e r o n e r e c e p t o r s ' , ' e s t r o g e n r e c e p t o r s ' , ' m e t a s t a s i s p l e a s e c i t e t h i s a r t i c l e a s ' , ' s a e e d i s a e d i h ' , ' g h a v a m n a s i r i m r ' , ' s h a h i d s a l e s s ' , ' t a g h i z a d e h a ' , ' m o h a m m a d i a n n . c o m p a r i s o n o f h o r m o n e r e c e p t o r s t a t u s i n p r i m a r y a n d r e c u r r e n t b r e a s t c a n c e r . i r a n j c a n c e r p r e v . 2 0 1 2 ' , ' 5 ( 2 ) ' , 6 9 , ' 7 3 . r e f e r e n c e s 1 . x a 0 s i m m o n s c ' , ' m i l l e r n ' , ' g e d d i e w ' , ' g i a n f e l i c e d ' , ' o l d f i e l d m ' , ' d r a n i t s a r i s x a 0 g ' , ' e t a l . d o e s c o n f i r m a t o r y t u m o r b i o p s y a l t e r t h e m a n a g e m e n t o f b r e a s t c a n c e r p a t i e n t s w i t h d i s t a n t m e t a s t a s e s ? a n n a l s o f o n c o l o g y j a n u a r y . 2 0 0 9 ' , 1 0 , ' 1 0 9 3 . 2 . w o o d w c ' , ' m u s s h b ' , ' s o l i n l j ' , ' o l o p a d o i . m a l i g n a n t t u m o r s o f t h e b r e a s t . i n ' , ' d e v i t a v t . c a n c e r p r i n c i p l e & ' , ' p r a c t i c e . 7 t h e d i t o n . p h i l a d e l p h i a ' , ' l i p p i n c o t t w i l l i a m s & ' , ' w i l k i n s ' , 2 0 0 5 , 1 4 2 4 , ' 5 . 3 . h a r v e y j m ' , ' c l a r k g m ' , ' o s b o r n e c k ' , ' a l l r e d d c . e s t r o g e n r e c e p t o r s t a t u s b y i m m u n o h i s t o c h e m i s t r y i s s u p e r i o r t o t h e l i g a n d ' , ' b i n d i n g a s s a y f o r p r e d i c t i n g r e s p o n s e t o a d j u v a n t e n d o c r i n e t h e r a p y i n b r e a s t c a n c e r . j c l i n o n c o l . 1 9 9 9 ' , 1 7 , ' 1 4 7 4 . 4 . e l l e d g e r m ' , ' f u q u a s a . e s t r o g e n a n d p r o g e s t e r o n e r e c e p t o r s . j r h a r r i s ' , ' e d . p h i l a d e l p h i a ' , ' l i p p i n c o t t w i l l i a m s & ' , ' w i l k i n s . 2 0 0 0 ' , ' 4 7 1 . 5 . o l o p a d e i ' , ' d e v i t a v t ' , ' c o n z e n s d ' , ' g r u s h k o t a . c a n c e r p r i n c i p l e & ' , ' p r a c t i c e . 8 t h e d i t o n . p h i l a d e l p h i a ' , ' l i p p i n c o t t w i l l i a m s & ' , ' w i l k i n s . 2 0 0 8 ' , 1 6 1 7 , ' 3 6 . 6 . l o w e r e e ' , ' g l a s s e l ' , ' b r a d l e y d a ' , ' b l a u r ' , ' h e f f e l f i n g e r s . i m p a c t o f m e t a s t a t i c e s t r o g e n r e c e p t o r a n d p r o g e s t e r o n e r e c e p t o r s t a t u s o n s u r v i v a l . b r e a s t c a n c e r r e s t r e a t . 2 0 0 5 m a r c h ' , ' 9 0 ( 1 ) ' , 6 5 , ' 7 0 . 7 . l i b d ' , ' b y s k o s h a ' , ' m o l t e n i a ' , ' d u d a r b . e s t r o g e n a n d p r o g e s t e r o n e r e c e p t o r c o n c o r d a n c e b e t w e e n p r i m a r y a n d r e c u r r e n t b r e a s t c a n c e r . j s u r g o n c o l . 1 9 9 4 o c t ' , ' 5 7 ( 2 ) ' , 7 1 , ' 7 . 8 . k u u k a s j ä r v i t ' , ' k o n o n e n j ' , ' h e l i n h ' , ' h o l l i k . l o s s o f e s t r o g e n r e c e p t o r i n r e c u r r e n t b r e a s t c a n c e r i s a s s o c i a t e d w i t h p o o r r e s p o n s e t o e n d o c r i n e t h e r a p y . j c l i n o n c o l . 1 9 9 6 s e p ' , ' 1 4 ( 9 ) ' , 2 5 8 4 , ' 9 . 9 . w a n g b ' , ' g u a n z z ' , ' l i u d g ' , ' l i n t y ' , ' z h a n g l ' , ' x i a z j ' , ' e t a l . d i s c o r d a n c e o f e s t r o g e n r e c e p t o r ( e r ) ' , ' p r o g e s t i n r e c e p t o r ( p r ) ' , ' a n d h e r ' , ' 2 r e c e p t o r s t a t u s e s b e t w e e n p r i m a r y a n d m e t a s t a t i c f o c u s e s o f b r e a s t c a n c e r . a i z h e n g . 2 0 0 4 d e c ' , ' 2 3 ( 1 2 ) ' , 1 7 1 0 , ' 3 . 1 0 . x a 0 k r i s t e k j ' , ' d m i t r o v i ć b ' , ' k u r b e l s ' , ' s a k i ć k ' , ' k r a j i n o v i ć z ' , ' b l a z i c e v i ć v ' , ' e t a l . t u m o r g r o w t h f r a c t i o n ' , ' e x p r e s s i o n o f e s t r o g e n a n d p r o g e s t e r o n e r e c e p t o r s ' , ' p 5 3 ' , ' b c l ' , ' 2 a n d c a t h e p s i n d a c t i v i t y i n p r i m a r y d u c t a l i n v a s i v e b r e a s t c a r c i n o m a a n d t h e i r a x i l l a r y l y m p h n o d e m e t a s t a s e s . c o l l a n t r o p o l . 2 0 0 7 d e c ' , ' 3 1 ( 4 ) ' , 1 0 4 3 , ' 7 . ' ]

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023